Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2—Virus Barrier Filter and HTST

Reference

1. 1.↵
   Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin; Q5A(R1); International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. September 1999.
2. 2.↵
   1. Shiratori M.,
   2. Kiss R.

   Risk Mitigation in Preventing Adventitious Agent Contamination of Mammalian Cell Cultures. Adv. Biochem. Eng. Biotechnol 2017. doi: 10.1007/10_2017_38.

   OpenUrlCrossRef
3. 3.↵
   1. Weaver B.,
   2. Rosenthal S.

   Viral Risk Mitigation for Mammalian Cell Culture Media. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 436–439.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Murphy M.,
   2. Quesada G. M.,
   3. Chen D.

   Effectiveness of Mouse Minute Virus Inactivation by High Temperature Short Time Treatment Technology: A Statistical Assessment. Biologicals 2011, 39 (6), 438–443.

   OpenUrlPubMed
5. 5.↵
   1. Schleh M.,
   2. Romanowski P.,
   3. Bhebe P.,
   4. Zhang L.,
   5. Chinniah S.,
   6. Lawrence B.,
   7. Bashiri H.,
   8. Gaduh A.,
   9. Rajurs V.,
   10. Rasmussen B.,
   11. Chuck A.,
   12. Dehghani H.

   Susceptibility of Mouse Minute Virus to Inactivation by Heat in Two Cell Culture Media Types. Biotechnol. Prog 2009, 25 (3), 854–860.

   OpenUrlPubMed
6. 6.↵
   1. Liu S.,
   2. Carroll M.,
   3. Iverson R.,
   4. Valera C.,
   5. Vennari J.,
   6. Turco K.,
   7. Piper R.,
   8. Kiss R.,
   9. Lutz H.

   Development and Qualification of a Novel Virus Removal Filter for Cell Culture Applications. Biotechnol. Prog 2000, 16 (3), 425–434.

   OpenUrlPubMed
7. 7.↵
   1. Mattila J.,
   2. Clark M.,
   3. Liu S.,
   4. Pieracci J.,
   5. Gervais T. R.,
   6. Wilson E.,
   7. Galperina O.,
   8. Li X.,
   9. Roush D.,
   10. Zoeller K.,
   11. Brough H.,
   12. Simpson-Platre C.

   Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration. PDA J. Pharm. Sci. Technol 2016, 70 (3), 293–299.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Manzke A.,
   2. Kleindienst B.

   Virus Risk Mitigation in Cell Culture Media. BioPharm International 2016, 29 (10), 20–25.

   OpenUrl
9. 9.↵
   1. Hermia J.

   Constant Pressure Blocking Filtration Laws-Application to Power-Law Non-Newtonian Fluids. Trans. Inst. Chem. Eng 1982, 60 (3), 183–187.

   OpenUrl
10. 10.↵
    1. Cao X.,
    2. Stimpfl G.,
    3. Wen Z. Q.,
    4. Frank G.,
    5. Hunter G.

    Identification and Root Cause Analysis of Cell Culture Media Precipitates in the Viral Deactivation Treatment with High-Temperature/Short-Time Method. PDA J. Pharm. Sci. Technol 2013, 67 (1), 63–73.

    OpenUrlAbstract/FREE Full Text